TrialClinical and vaccine immunology : CVI2008

Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.

Ashok Cattamanchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.